Literature DB >> 21766221

Progression of new onset to established persistent atrial fibrillation: an implantable device-based analysis with implications for clinical classification of persistent atrial fibrillation.

Rangadham Nagarakanti1, Sanjeev Saksena, Douglas Hettrick, Jodi L Koehler, Andrea Grammatico, Luigi Padeletti.   

Abstract

INTRODUCTION: The temporal patterns of onset of persistent atrial fibrillation (AF) recurrences leading to established persistent AF is currently unknown.
METHODS: Three hundred thirty patients with a history of paroxysmal AF and bradycardia (mean age, 70 ± 10 years; 61% male) with implanted pacemakers that automatically recorded the cumulative daily atrial tachyarrhythmia (AT) burden were included in the analysis. Persistent AF was defined as device data showing ≥7 consecutive days with ≥23 h of AT. We analyzed the pattern and duration of persistent AF recurrences and time to each persistent AF episode recurrence.
RESULTS: Seventy-eight patients (24%) developed their first persistent AT/AF after 147 ± 149 days. Follow up ranged from 14 to 499 days. Median AF burden in the week prior to persistent AF was 3.5 h/day. Fifty-four patients (16%) had a minimum of 180 days follow up after initial detection of persistent AF. Three of 54 patients (6%) immediately developed established AF; 32 of 51 patients (63%) returned to sinus rhythm but then had a second persistent AF event. These 32 patients had a minimum of 90 days follow up and 25 of these 32 patients (78 %) had a third persistent AF event. Time to recurrence analysis showed progressive abbreviation in persistent AF onset. The median durations of the first, second, and third persistent AF events were 16, 13, and 17 days, respectively.
CONCLUSIONS: (1) The time to first, second, and third persistent AF recurrences progressively decreases with a high likelihood of established persistent AF within 9 months of onset. (2) These data support intermittent but frequent AF monitoring for the detection of persistent AF recurrences to assess the efficacy of rhythm control interventions.

Entities:  

Mesh:

Year:  2011        PMID: 21766221     DOI: 10.1007/s10840-011-9601-1

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  25 in total

1.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

Review 2.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

3.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

4.  Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence.

Authors:  Gerhard Hindricks; Christopher Piorkowski; Hildegard Tanner; Richard Kobza; Jin-Hong Gerds-Li; Corrado Carbucicchio; Hans Kottkamp
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

5.  Amiodarone versus sotalol for atrial fibrillation.

Authors:  Bramah N Singh; Steven N Singh; Domenic J Reda; X Charlene Tang; Becky Lopez; Crystal L Harris; Ross D Fletcher; Satish C Sharma; J Edwin Atwood; Alan K Jacobson; H Daniel Lewis; Dennis W Raisch; Michael D Ezekowitz
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

6.  Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies.

Authors:  Helmut Purerfellner; Anne M Gillis; Reece Holbrook; Douglas A Hettrick
Journal:  Pacing Clin Electrophysiol       Date:  2004-07       Impact factor: 1.976

7.  Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia.

Authors:  Luigi Padeletti; Helmut Pürerfellner; Stuart W Adler; Theodore J Waller; Mark Harvey; Lewis Horvitz; Reece Holbrook; Kitty Kempen; Andrew Mugglin; Douglas A Hettrick
Journal:  J Cardiovasc Electrophysiol       Date:  2003-11

8.  Total atrioventricular nodal ablation increases atrial fibrillation burden in patients with paroxysmal atrial fibrillation despite continuation of antiarrhythmic drug therapy.

Authors:  Rik Willems; D George Wyse; Anne M Gillis
Journal:  J Cardiovasc Electrophysiol       Date:  2003-12

9.  Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial.

Authors:  Sheba Ahmed; Michiel Rienstra; Harry J G M Crijns; Thera P Links; Ans C P Wiesfeld; Hans L Hillege; Hans A Bosker; Dirk J A Lok; Dirk J Van Veldhuisen; Isabelle C Van Gelder
Journal:  JAMA       Date:  2008-10-15       Impact factor: 56.272

10.  The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study.

Authors:  Taya V Glotzer; Emile G Daoud; D George Wyse; Daniel E Singer; Michael D Ezekowitz; Christopher Hilker; Clayton Miller; Dongfeng Qi; Paul D Ziegler
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-08-04
View more
  5 in total

1.  Clinical trials of antiarrhythmic therapies and optimizing health care resource deployment: the need for a paradigm shift.

Authors:  Sanjeev Saksena
Journal:  J Interv Card Electrophysiol       Date:  2012-01       Impact factor: 1.900

Review 2.  Management of atrial fibrillation in bradyarrhythmias.

Authors:  Giuseppe Boriani; Luigi Padeletti
Journal:  Nat Rev Cardiol       Date:  2015-03-17       Impact factor: 32.419

3.  Building Atrial Fibrillation Awareness: Is it Time to get Beyond the Top Line?

Authors:  Sanjeev Saksena
Journal:  J Atr Fibrillation       Date:  2013-06-30

4.  The natural history of atrial fibrillation in patients with permanent pacemakers: is atrial fibrillation a progressive disease?

Authors:  R A Veasey; C Sugihara; K Sandhu; G Dhillon; N Freemantle; S S Furniss; A N Sulke
Journal:  J Interv Card Electrophysiol       Date:  2015-07-03       Impact factor: 1.900

5.  Clinical, Echocardiographic, and Electrocardiographic Predictors of Persistent Atrial Fibrillation after Dual-Chamber Pacemaker Implantation: An Integrated Scoring Model Approach.

Authors:  Min Soo Cho; Jun Kim; Ju Hyeon Kim; Minsu Kim; Ji Hyun Lee; You Mi Hwang; Uk Jo; Gi-Byoung Nam; Kee-Joon Choi; You-Ho Kim
Journal:  PLoS One       Date:  2016-08-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.